These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 17187310)

  • 1. How do patents affect research investments?
    Williams HL
    Annu Rev Econom; 2017 Aug; 9():441-469. PubMed ID: 29104716
    [No Abstract]   [Full Text] [Related]  

  • 2. Getting to personalized cancer medicine: taking out the garbage.
    Compton C
    Cancer; 2007 Oct; 110(8):1641-3. PubMed ID: 17763370
    [No Abstract]   [Full Text] [Related]  

  • 3. Personalized medicine: challenges in assessing and capturing value in the commercial environment.
    Ferrara J
    Expert Rev Mol Diagn; 2006 Mar; 6(2):129-31. PubMed ID: 16512770
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular diagnostics and personalized medicine. IBC Life Sciences Conference on Pharmacogenomics, June 24-25, 2003, London, UK.
    Sanders R
    Pharmacogenomics; 2003 Sep; 4(5):541-5. PubMed ID: 14518454
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The second annual Burrill personalized medicine conference.
    Razvi ES
    IDrugs; 2007 Jan; 10(1):26-9. PubMed ID: 17187310
    [No Abstract]   [Full Text] [Related]  

  • 7. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
    Walk EE
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine.
    Bissonnette L; Bergeron MG
    Expert Rev Mol Diagn; 2006 May; 6(3):433-50. PubMed ID: 16706745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.